Results 201 to 210 of about 25,779 (305)

Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study [PDF]

, 2015
Masahiro Osawa, Shoji Kudoh, Fumikazu Sakai, Masahiro Endo, Tetsuya Hamaguchi, Yumiko Ogino, Miyo Yoneoka, Motonobu Sakaguchi, Hiroyuki Nishimoto, Akihiko Gemma   +9 more
openalex   +1 more source

An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: initial patient characteristics [PDF]

, 2013
Ardissino, Gianluigi, Ariceta, Gema, Beauchamp, Jon, Cohen, David, Fremeaux-Bacchi, Véronique, Greenbaum, Larry A, Johnson, Sally, Licht, Christoph, Ogawa, Masayo, Schaefer, Franz, Vande Walle, Johan   +10 more
core  

PCASE4 BRIDGING THE GAP OF EVIDENCE AND COSTEFFECTIVENESS: THE PRAGMATIC APPROACH USING ECONOMIC MODELLING TO ASSESS THE COSTEFFECTIVENESS FOR ASSISTIVE TECHNOLOGIES (AT) IN THE UK-BOTH PRE-AND POSTMARKETED

, 2008
MP Retsa, K. S. Down, A Guhl, Martin Ferguson-Pell   +3 more
openalex   +1 more source

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study [PDF]

, 2015
Rocco Totaro, Caterina Di Carmine, Gianfranco Costantino, Roberta Fantozzi, Paolo Bellantonio, Aurora Fuiani, Ciro Mundi, Stefano Ruggieri, Carmine Marini, Antonio Carolei   +9 more
openalex   +1 more source

Efficacy and tolerability of treatment with lacosamide in children: Postmarketing experience from the Middle East

Seizure, 2020
G. Hmaimess, S. Sabbagh, M. Dirani, M. Hotait, A. Beydoun, W. Nasreddine   +5 more
semanticscholar   +1 more source

Enhancing postmarketing surveillance: continuing challenges [PDF]

, 2015
Dustin D. French, Curtis E. Margo, Robert R. Campbell   +2 more
openalex   +1 more source

A multicenter, postmarketing surveillance of elobixibat in patients with chronic constipation in Japan: A final analysis report. [PDF]

SAGE Open Med
Nakajima A, Umeyama M, Higashikawa M, Shimada Y, Arai Y.   +4 more
europepmc   +1 more source

The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting [PDF]

, 2016
Paul Coplan, HD Chilcoat, SF Butler, Edward M. Sellers, Aditi Kadakia, V. Harikrishnan, J. David Haddox, Richard C. Dart   +7 more
openalex   +1 more source

Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan. [PDF]

Clin Rheumatol
Nanki T, Yamaguchi T, Umetsu K, Tanabe R, Maeda N, Kanazawa M, Furuno Y, Matsuda S, Takemoto S, Asao K, Kamiuchi T.   +10 more
europepmc   +1 more source

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events. [PDF]

Drugs Real World Outcomes
Kingsbury CM, Zvorsky I, Spelman K.
europepmc   +1 more source